期刊文献+

^(125)I标记反义肽核酸对SKOV3细胞CerbB-2 mRNA和Her-2蛋白表达的抑制作用 被引量:1

Depressed Expression of CerbB-2 mRNA and Her-2 Protein in Human Ovarian Cancer Cell Line SKOV3 by ^(125)I Labeled Antisense Peptide Nucleic Acid
原文传递
导出
摘要 目的探讨利用脂质体转染125I标记的CerbB-2反义肽核酸(asPNA)阻断人卵巢癌细胞株SKOV3中CerbB-2mRNA翻译并抑制Her-2蛋白表达的作用。方法 (1)125I用CH-T法标记CerbB-2-asPNA,测定其标记率和放化纯。(2)分对照组、非标记分子探针组和125I标记反义肽核酸组,运用RT-PCR法检测各组细胞CerbB-2mRNA的翻译。(3)运用流式细胞仪检测各组细胞的Her-2蛋白表达率。结果 (1)125I标记CerbB-2-asPNA的标记率为(56.90±4.38)%,放射化学纯度为(87.00±0.99)%,放射性浓度为3.7MBq/ml,化学浓度为5.00μmol/L。(2)125I标记CerbB-2-asPNA作用SKOV3细胞24h后,SKOV3细胞CerbB-2在mRNA水平上明显下降,与SKOV3细胞对照组比较,差异有统计学意义(P<0.01)。(3)125I标记CerbB-2-asPNA作用SKOV3细胞24h后,细胞的Her-2蛋白表达率降低幅度较大,与SKOV3细胞组对比,两者间差异有统计学意义(P<0.01)。结论 125I-L-CerbB-2-asP-NA对人卵巢癌细胞株SKOV3CerbB-2基因表达在mRNA翻译和蛋白表达水平上均有抑制作用。 Objective To investigate the inhibitory effect of 125I labeled antisense peptide nucleic acid ( 125I-asPNA) transfected by liposome to block CerbB-2 mRNA translation and Her-2 protein expression in the human ovarian epithelial cancer cell lines SKOV3. Methods ( 1) The method of 125I labeled CerbB-2 antisense peptide nucleic acid with the CH-T was used; meanwhile its tagging ratio and radiochemical purity were detected. ( 2) Three experimental groups were divided in the experiment: the control group,no labeled molecule probes group and 125I labeled antisense peptide nucleic acid group; The translation of CerbB-2 mRNA in SKOV3 was detected by reverse transcription-polymerase chain reaction ( RTPCR) . ( 3) The expression ratio of Her-2 protein in cell by flow cytometry was detected. Results ( 1) 125 I-asPNA’s labeled ratio was ( 56. 90 ± 4. 38) % ,radiochemical purity was ( 87. 00 ± 0. 99) % ,radioactive concentration 3. 7 MBq/ml and chemistry concentration 5. 00 μmol/L. ( 2) After 24h treated by 125 I-L-asPNA,the CerbB-2 in SKOV3 cell lines declined obviously on mRNA level,their differences were significant ( P 0. 01) compared with those in the SKOV3 cell control group. ( 3) Flow cytometry indicated that the expression ratio of Her-2 protein in SKOV3 cell lines which was treated for 24 h by 125I-L-asPNA declined greatly,their differences were significant compared with those in the SKOV3 cell control group( P 0. 01) . Conclusions 125I-L-asPNA can depress the CerbB-2 gene expression of the human ovarian epithelial cancer cell lines SKOV3 on the mRNA translation and protein expression level.
出处 《苏州大学学报(医学版)》 CAS 北大核心 2010年第5期1014-1017,共4页 Suzhou University Journal of Medical Science
基金 苏州市社会发展项目(SS0532)
关键词 125I 标记 CERBB-2 反义肽核酸 卵巢癌 125I CerbB-2 antisense peptide nucleic acid human ovarian epithelial cancer
  • 相关文献

参考文献2

  • 1E. G. Marcusson,B. R. Yacyshyn,W. R. Shanahan,N. M. Dean. Preclinical and clinical pharmacology of antisense oligonucleotides[J] 1999,Molecular Biotechnology(1):1~11
  • 2R. Kronenwett,R. Haas. Antisense strategies for the treatment of hematological malignancies and solid tumors[J] 1998,Annals of Hematology(1-2):1~12

同被引文献6

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部